Showing 1 - 4 results of 4 for search 'Jérôme Msihid', query time: 0.02s Refine Results
  1. 1
    Efficacy of avalglucosidase alfa on forced vital capacity percent predicted in treatment-naïve patients with late-onset Pompe disease: A pooled analysis of clinical trials

    Efficacy of avalglucosidase alfa on forced vital capacity percent predicted in treatment-naïve patients with late-onset Pompe disease: A pooled analysis of clinical trials by Tahseen Mozaffar, Lionel Riou França, Jérôme Msihid, Pragya Shukla, Irina Proskorovsky, Tianyue Zhou, Magali Periquet, Kristina An Haack, Laurence Pollissard, Volker Straub

    Published 2024-09-01
    Get full text
    Article
  2. 2
    Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma recruited from Japanese centers in the phase 3 LIBERTY ASTHMA TRAVERSE study

    Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma recruited from Japanese centers in the phase 3 LIBERTY ASTHMA TRAVERSE study by Yuji Tohda, Yoichi Nakamura, Takao Fujisawa, Motohiro Ebisawa, Jerome Msihid, Michel Djandji, Benjamin Ortiz, Juby A. Jacob-Nara, Yamo Deniz, Paul J. Rowe, Masato Ishida, Kazuhiko Arima

    Published 2023-01-01
    Get full text
    Article
  3. 3
    Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polyps

    Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polyps by Philippe Gevaert, Stella E Lee, Russell A Settipane, Martin Wagenmann, Jérôme Msihid, Shahid Siddiqui, Scott Nash, Juby A Jacob‐Nara, Asif H Khan, Siddhesh Kamat, Chien‐Chia Chuang

    Published 2023-01-01
    Get full text
    Article
  4. 4
    P1675: SUTIMLIMAB PROVIDES SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: OPEN-LABEL EXTENSION OF THE PHASE 3 CADENZA STUDY

    P1675: SUTIMLIMAB PROVIDES SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: OPEN-LABEL EXTENSION OF THE PHASE 3 CAD... by Alexander Röth, Catherine M Broome, Wilma Barcellini, Bernd Jilma, Quentin A Hill, David Cella, Tor Henrik Anderson Tvedt, Masaki Yamaguchi, Irina Murakhovskaya, Michelle Lee, Frank Shafer, Marek Wardęcki, Deepthi Jayawardene, Ronnie Yoo, Jerome Msihid, Ilene C Weitz

    Published 2023-08-01
    Get full text
    Article

Search Tools: